Centre for Diabetes and Endocrinology

What Centre for Diabetes and Endocrinology does

Centre for Diabetes and Endocrinology (CDE) is a South Africa-based, privately held diabetes care organisation founded in 1994 and headquartered in Johannesburg. The company delivers integrated, multidisciplinary diabetes management through three tiers of contracted care plans (Traditional, Standard, Micare) to members of 10 contracted medical schemes, and operates walk-in diagnostic centres and Type 1 Centres of Excellence across 9 provinces. CDE's clinical delivery is supported by an AI-enabled diagnostic stack comprising AI Pathology, AI Eyecare (fundal cameras with AI retinopathy interpretation), and AI Renal Care, alongside a CRF 21-accredited electronic system for clinical trials and POPIA-compliant pharmacovigilance.

CDE operates a multi-revenue-stream platform spanning managed care subscriptions with healthcare funders, B2B pharmaceutical services (reimbursement support, patient support programmes, real-world evidence data, and clinical trial execution for 15+ major pharma partners including AbbVie, AstraZeneca, Bayer, Pfizer, GSK, Novo Nordisk, and Sanofi), retail chronic pharmacy, an e-commerce storefront at cdeonline.co.za, and a CDE Academy education line that includes CPD-accredited courses and a University of South Wales-validated Postgraduate Diploma and MSc in Diabetes. Distribution is enterprise-led: direct contracts with medical schemes and pharmaceutical companies, plus a Diabetes Excellence Network of affiliated practitioners.

The organisation holds accreditations that anchor its regulatory moat, including Council for Medical Schemes accreditation as a Managed Care Organisation for Active Disease Risk Management Services, GCP certification for clinical trial staff, and POPIA-compliant data systems. Affiliation with 3Sixty Global Solutions Group (visible in website branding) and a 2016 investment from KLEOSS Capital indicate backing beyond founder capital, supporting continued investment in AI diagnostics, nationwide centre buildout, and academic education expansion.

Name

Centre for Diabetes and Endocrinology

Legal name

Centre for Diabetes and Endocrinology

Website

https://cdediabetes.co.za

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

CDE is a South Africa-based, privately held diabetes care organisation founded in 1994 that delivers managed diabetes care programmes, AI-enabled diagnostics, clinical trial services, and accredited education to medical schemes, pharmaceutical companies, and people living with diabetes across 9 provinces.

Ownership category

akta.pro rank

Product category

Diabetes Care Management

NAICS

Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Type 1 Diabetes Care (HLAKADAB)

akta.pro secondary industries

Utilization Management, Appropriateness Criteria & Prior Authorization CDS (HLACAGAM), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Charge Capture & Clinical Documentation Improvement (CDI) for Billing (HLACACAF)

Keywords

• Diabetes care management
• Managed healthcare services
• Diabetes education programs
• Clinical trial services
• AI diagnostic services

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Managed Care Programmes: CDE provides diabetes managed healthcare programmes to healthcare funders (medical schemes). The CDE Care Programmes facilitate and ensure that good diabetes management principles are applied, resulting in improved health for health consumers and an improved health risk and cost burden for healthcare funders.
2. Pharmaceutical Reimbursement Support: CDE provides reimbursement support services to pharmaceutical companies, facilitating access, adoption, adherence and persistence for their products. This is provided as a more cost-effective alternative to running an in-house programme.
3. Patient Support Programmes: Health consumer support programmes educating, empowering and supporting health consumers living with chronic conditions. Provides real-world evidence data collection for pharmaceutical companies.
4. Clinical Trial Services: Clinical trial centre of excellence and network hub providing study feasibility, GCP-compliant trials, health consumer education, electronic diaries, remote data capturing, regulatory submissions, contract and budget review services.
5. Academy Education and Training: CDE Academy provides CPD-accredited courses, foundation courses, postgraduate forum, journal clubs, webinars, and literature reviews for healthcare professionals. Also offers nutrition education materials for purchase.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

CDE provides higher levels of multidisciplinary diabetes care for persons with diabetes mellitus in South Africa, integrating AI-powered diagnostics (pathology, eyecare, renal care), managed care programmes for medical schemes, clinical trial services, reimbursement and patient support programmes for pharmaceutical companies, and education through the CDE Academy. Services are delivered through a network of diagnostic centres, affiliated practitioners, and retail chronic pharmacy clinics, supported by a CRF 21-accredited electronic system for clinical trials and pharmacovigilance.

Product overview

Centre for Diabetes and Endocrinology (CDE) operates as a diabetes care organization established in 1994, offering a comprehensive integrated platform of diabetes management services. The core portfolio includes AI-powered diagnostic services (AI Pathology, AI Eyecare, AI Renal Care), managed care programmes (Traditional Care Plan, Standard Care Plan, Micare Plan), the CDE Academy education platform with CPD-accredited courses and academic partnerships with University of South Wales, clinical trial services, reimbursement support for pharmaceutical companies, and patient support programmes. CDE also operates retail pharmacy centres, an online store, and maintains a nationwide Diabetes Excellence Network with Type 1 Centres of Excellence. The organization employs a multidisciplinary team approach providing holistic, person-centred care under one roof.

Differentiator

Problem solved

Functional benefit

Products and services

• AI Pathology AI-enabled pathology laboratory service providing diagnostic, monitoring, and screening from routine to specialized pathology testing at CDE diagnostic centres nationally. For patients referred through CDE practitioners and medical scheme networks.
• AI Eyecare AI-powered eye care evaluation and treatment in partnership with ophthalmologists and optometrists, using fundal cameras with AI interpretation for retinopathy screening at CDE diagnostic centres. For people with diabetes requiring diabetic retinopathy screening.
• AI Renal Care AI-enabled renal care evaluation and treatment in partnership with nephrologists at CDE diagnostic centres. For people with diabetes requiring renal monitoring and management.
• CDE Managed Care Diabetes managed healthcare programmes contracted with medical schemes and healthcare funders, facilitating good diabetes management principles and improving health risk and cost burden. For medical schemes and healthcare funders.
• CDE Diabetes Management Programme (DMP) Core programme based on integrated diabetes care principles, offering a multidisciplinary team approach (endocrinologists, podiatrists, ophthalmologists, dietitians, certified diabetes educators) for people living with diabetes.
• CDE Traditional Care Plan Diabetes care plan providing enrolled members with doctor consultations, dietitian consultations, podiatry, and diabetes nurse educator consultations under the managed care programme.
• CDE Standard Care Plan Diabetes care plan offering specialized therapy review plus 24-hour diabetes hotline access for enrolled members.
• Micare Plan Member-centric diabetes care plan providing tailored treatment plans for each enrolled member, including free glucose meter benefits.
• Type 1 Centres of Excellence Specialised walk-in diagnostic centres across multiple South African provinces offering comprehensive multidisciplinary services for people with Type 1 diabetes.
• CDE Reimbursement Support Programme B2B service for pharmaceutical companies providing reimbursement support, patient advocacy, formulary advice, and specialist reviews to facilitate access, adoption, adherence and persistence for their products.
• Health Consumer Support Programmes Patient education, empowerment, and support programmes providing knowledge and skills for self-management of chronic conditions, with real-world evidence data collection for pharmaceutical partners.
• CDE Clinical Trials Clinical trial centre of excellence providing study feasibility, GCP-compliant trials, health consumer education, electronic diaries, remote data capture, regulatory submissions, and contract/budget review across diabetes, cardiovascular disease, and ophthalmology therapeutic areas. For pharmaceutical companies and CROs.
• CDE Academy Educational platform offering CPD-accredited courses, foundation courses, journal clubs, webinars, and quarterly literature reviews for healthcare professionals with an interest in diabetes care.
• CDE Academy Foundation Course in Diabetes Care Online foundation course with 16 modules facilitated by clinical specialists, offering 30 contact hours and 30 Continuing Education Units. For healthcare professionals.
• CDE Academy Associate Membership Post-foundation course membership providing access to the learning community, event discounts, and the CDE Academy Clinical Practice Toolbox for healthcare professionals.
• Postgraduate Diploma in Diabetes Care / MSc in Diabetes Postgraduate Diploma and MSc Degree in Diabetes delivered in partnership with the University of South Wales (UK), with CDE Faculty members performing tutoring roles. For healthcare professionals.
• Very Low-Calorie Diet (VLCD) Course for Healthcare Professionals Course on Very Low-Calorie Diet programme management for obesity, offering 23 CPD points upon completion. For healthcare professionals (ZAR 2300 incl. VAT).
• Retail Chronic Pharmacy Centres Pharmacy clinics run by CDE specialised nurses providing continuous monthly monitoring for members, located nationally.
• Nutrition Services Diet and nutrition counselling for people living with diabetes, supported by educational handouts and materials.
• CDE Consultancy Services Consultancy services in diabetes care, leveraging CDE's multidisciplinary team, clinical expertise, and operational experience to advise healthcare organisations.

Quantifiable outcome

• Multidisciplinary team approach achieving 7.8% higher proportion of clients achieving target HbA1c of less than 7% compared to usual care (based on Siriraj Continuity of Care Clinic study)
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

26 partnerships are on record, tiered core.

• Anglo Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Anglovaal Group Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• BankmedcoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Barloworld Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Libcare Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Multichoice Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Pick n Pay Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• SABC Medical Aid SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Sizwe Hosmed Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• Tsogo Sun Group Medical SchemecoreChannel Partner/ Reseller/ DistributorContracted medical scheme partner providing CDE Care Programme access to their members. Health consumers who are members of these schemes are able to join as members of the CDE Care Programme.
• AbbVie InccoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• AstraZenecacoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• BayercoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Boehringer IngelheimcoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Bristol-Myers SquibbcoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Covance/PfizercoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• GlaxoSmithKlinecoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Intarcia TherapeuticscoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• JanssencoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Lilly & CompanycoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Merck/ParexelcoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• MylancoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Novo NordiskcoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• SanoficoreStrategic or Co-development PartnerPharmaceutical company partner involved in clinical trials conducted at CDE's Clinical Trial Centre of Excellence.
• Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA)coreStrategic or Co-development PartnerCDE is a member of SEMDSA. The SEMDSA guidelines for the management of Type 2 diabetes are based on international best-practice, and the CDE adopts these guidelines within their programmes of care.
• University of South Wales (UK)coreStrategic or Co-development PartnerCDE has partnered with University of South Wales to provide Postgraduate Diploma in Diabetes Care and MSc Degree in Diabetes. CDE Faculty members perform a tutoring role for these courses.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Mediclinic Southern Africa: Largest private hospital group in South Africa providing inpatient and outpatient specialty care including endocrinology. Competes for the same specialist consultation and chronic-care patient pool as CDE.
• Momentum Health Solutions: South African health administrator and managed-care provider offering chronic-disease management programmes to medical-scheme members. Direct overlap with CDE's managed-care programmes for the same South African scheme customers.
• Netcare: Major South African private hospital and primary-care network. Adjacent incumbent delivering multidisciplinary specialty services and chronic-disease management to medical-scheme patients.

Direct peers

• Joslin Diabetes Center: Harvard-affiliated specialty diabetes care, research and education provider in the US. Closely comparable multidisciplinary, education-driven diabetes specialist model to CDE's Centres of Excellence.
• Steno Diabetes Center: Danish specialised diabetes care and research centre running multidisciplinary outpatient programmes. Comparable integrated clinical-research-education model to CDE.
• Discovery Health: South Africa's largest medical-scheme administrator and managed-care operator with its Vitality wellness programme. Directly comparable to CDE in selling diabetes and chronic-disease management services to the same pool of South African medical schemes.
• DPV (Diabetes-Praxis-Verbund): Germany's largest network of specialist diabetes practices, providing structured diabetes care under bundled reimbursement contracts. A direct international analog to CDE's Diabetes Excellence Network and care-plan model.
• AfroCentric Group: JSE-listed South African managed-care group providing disease management and pharmaceutical benefit management to medical schemes. Operates in the same managed-care/disease-management environment as CDE's Care Programmes.

Emerging players

• Omada Health: US virtual chronic-disease management platform covering diabetes, hypertension and obesity for payers and employers. Comparable as an outcomes-based digital alternative to CDE's multidisciplinary care programmes.
• Virta Health: US digital diabetes reversal platform delivering physician-supervised, app-based care to insurers and employers. Competes for the same payer diabetes-management wallet as CDE, particularly on Type 2 diabetes outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cde_diabetes
• YouTubeyoutube.com/channel/UC7S_xuQZVN0Qgljry8xzAyQ
• Facebookfacebook.com/cde-your-partner-in-diabetes-1427714494189015
• LinkedInlinkedin.com/company/cdediabetes
• Instagraminstagram.com/cdehealthcare

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre for Diabetes and Endocrinology